IMPORTANCE US hospitals receive financial penalties for excess risk-standardized 30-day readmissions and mortality in Medicare patients. Under current policy, readmission prevention is incentivized over 10-fold more than mortality reduction.
I n fiscal year (FY) 2013, the Centers for Medicare & Medicaid Services (CMS) began penalizing hospitals in the United States under the Hospital Readmissions Reduction Program for excess risk-standardized 30-day readmissions in Medicare patients with heart failure (HF), pneumonia (PNA), and acute myocardial infarction (AMI). In FY 2014, the Hospital Value-Based Purchasing Program began penalizing hospitals with higher than expected risk-standardized 30-day mortality for these diagnoses. Readmission and death are competing but weakly correlated outcomes, leading to the belief that hospitals with low mortality are not more likely to receive readmission penalties. 1 Currently, unbalanced incentives favor readmission prevention over mortality reduction. Patients who die within 30 days without rehospitalization are excluded from readmission metrics. Moreover, financial penalties are more than 10-fold greater for readmission than for mortality. We investigated how hospital penalties might change if 30-day readmission and mortality were weighted equally. We created an excess combined outcome ratio (ECOR AGG ) by averaging excess readmission and mortality:
Methods

Hospital
ECOR AGG = (ERR AGG + EMR AGG )/2. We examined associations between readmission penalties, ERR AGG , EMR AGG , and ECOR AGG . We used analysis of variance to compare readmission penalties in hospitals with concordant and discordant performance by ERR AGG and ECOR AGG . Because the decision to equally weight mortality and readmission was arbitrary (and conservative), we performed sensitivity analyses with mortality weighted 2 and 5 times as much as readmission. Analyses were performed using Stata version 10.0 (StataCorp LP).
Results
In 1963 US hospitals with complete data for analysis, FY 2014 readmission penalties (0%-2% of DRG reimbursement) closely tracked excess readmissions (r = 0.81; P < .001), but were minimally and inversely associated with excess mortality (r = −0.12; P < .001) and only modestly correlated with excess combined readmission and mortality (r = 0.36; P < .001). The associations between condition-specific excess readmission and mortality were weak (HF: r = -0.21; P < .001) or absent (PNA: r < 0.001; P = .99 and AMI: r = 0.002; P = .94) and similar to those reported in previous Medicare cohorts for these diagnoses. 1 As shown in both Figure 1 and Figure 2 , 17% of hospitals had an ERR AGG ratio greater than 1 and received readmission penalties, yet had an ECOR AGG ratio of less than 1 (ie, superior combined outcomes if mortality and readmission were considered equally important). Conversely, 16% of hospitals had an ERR AGG ratio less than 1 and received little or no readmission penalty, yet had an ECOR AGG ratio greater than 1 (ie, inferior combined outcomes).
With mortality weighted twice as much as readmission, 21% of hospitals had an ERR AGG ratio greater than 1 and an ECOR AGG ratio less than 1, and 23% of hospitals had an ERR AGG ratio less than 1 and an ECOR AGG ratio greater than 1. With mortality weighted 5 times as much as readmission, 24% of hospitals had an ERR AGG ratio greater than 1 and an ECOR AGG ratio less than 1, and 27% of hospitals had an ERR AGG ratio less than 1 and an ECOR AGG ratio greater than 1. In other words, in FY 2014 more than half of US hospitals would have been misclassified for CMS penalties if death were considered 5 times more important than readmission.
Discussion
For FY 2014, CMS financial penalties for one-third of US hospitals would likely have been substantially different if the methodology equally weighted 30-day readmission and mortality. These discrepancies increased as mortality was weighted more heavily.
The Hospital Readmission Reduction Program, implemented in 2012 as part of the Patient Protection and Affordable Care Act, was designed to "improve quality of care… by incentivizing the reduction of hospital readmissions" and "reward hospitals for delivering services of higher value." 4 Mortality risk-standardization for HF, PNA, and MI is reasonably accurate, 5 and publicly reported mortality for these conditions reflects hospital mortality rates for other diagnoses. 6 By 7
Financial penalties for excess 30-day readmissions, which cost some hospitals millions of dollars per year, clearly affect resource usage. Shortly after the advent of the Hospital Readmission Reduction Program, nearly 9 in 10 US hospitals reported creating quality improvement teams to reduce HF rehospitalizations, 8 the primary driver of CMS readmission penalties. 9 Some benefits have clearly accrued from this effort, as discharged patients now receive better coordination of care transitions, and 30-day readmissions have slightly decreased. 10 Yet relatively few readmissions are truly preventable, 11 and less attention has been paid the other side of the equation: What if some readmissions are appropriate and necessary to prevent deaths? 12 While the rates are not directly comparable, it is interesting to note that, after more than a decade of steady decline, age-adjusted mortality rates for US patients with HF have recently increased at the same time 30-day readmission rates decreased.
10,13
Health care performance metrics are proliferating rapidly and are increasingly used to incentivize provider and system behavior. This is occurring without full consideration of misaligned incentives and the potential for unintended consequences. In FY 2016 the maximum penalty for high 30-day mortality rates is 0.2% of DRG payments, compared with 3.0% maximum DRG penalty for excess 30-day readmissions. Chronic obstructive pulmonary disease and stroke now also appear on the list of nonsurgical diagnoses penalized for excess 30-day readmissions. Similar concerns have been raised related to insufficient risk standardization and lack of evidence on how to prevent readmissions for these conditions, 14, 15 and there are no corresponding penalties for excess 30-day mortality.
Conclusions
The concept of quality-adjusted life years is a widely accepted method of assessing and improving health care decision making, and is based on patient-derived health utility of various states compared with death or perfect wellness. Again considering the case of hospitalized patients with HF, even surviving 3 or more cardiovascular rehospitalizations has rela- For the readmission low, high combined mortality and readmission population, the ERR Agg was less than 1 and the ECOR Agg was more than 1. For the readmission high, low combined mortality and readmission population, the ERR Agg was greater than 1 and the ECOR Agg was less than 1. DRG indicates diagnosis-related group; ECOR Agg , excess combined outcome ratio; ERR Agg , excess readmission ratio. The top left quadrant represents a low readmission, high combined mortality and readmission population (ERR Agg < 1, ECOR Agg > 1); the bottom right quadrant represents a high readmission, low combined mortality and readmission population (ERR Agg > 1, ECOR Agg < 1). ECOR Agg indicates excess combined outcome ratio; ERR Agg , excess readmission ratio.
